Azathioprine hypersensitivity presenting as septic shock with encephalopathy
暂无分享,去创建一个
[1] J. Pascual,et al. Neutrophilic dermatosis caused by azathioprine hypersensitivity , 2012, International journal of dermatology.
[2] T. Yong,et al. Azathioprine hypersensitivity presenting as cardiogenic shock and Sweet's syndrome in a patient with microscopic polyangiitis. , 2012, Internal medicine.
[3] Suneel C. Mundkur,et al. Disseminated strongyloidiasis in a immunocompromised host. , 2011, Indian pediatrics.
[4] K. Sky,et al. The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome. , 2011, Journal of the American Academy of Dermatology.
[5] T. Staiano,et al. Severe muscular weakness as an isolated symptom of azathioprine hypersensitivity. , 2011, Inflammatory bowel diseases.
[6] M. J. Kim,et al. Azathioprine hypersensitivity presenting as sweet syndrome in a child with ulcerative colitis. , 2011, Indian pediatrics.
[7] C Hassan,et al. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease , 2002, Alimentary pharmacology & therapeutics.
[8] L. Lennard,et al. TPMT in the treatment of Crohn's disease with azathioprine , 2002, Gut.
[9] J. Sanderson,et al. Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK. , 2002, QJM : monthly journal of the Association of Physicians.
[10] S. Knowles,et al. Azathioprine hypersensitivity reactions: Caution upon rechallenge , 1997, Muscle & nerve.
[11] J. Roujeau,et al. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). , 1996, Seminars in cutaneous medicine and surgery.
[12] J. H. Harrison,et al. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. , 1963, Annals of plastic surgery.
[13] A. Eddleston,et al. Hypersensitivity and jaundice due to azathioprine. , 1980, Postgraduate medical journal.
[14] Elion Gb,et al. The metabolism of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio]purine (B.W. 57-323) in man. , 1960 .
[15] G. Hitchings,et al. The metabolism of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio]purine (B.W. 57-323) in man. , 1960, Cancer chemotherapy reports.